Clinical trials - Press Releases

Date	Title	Company
22-May-2020	Tiziana Lifesciences Announces Intention to Demerge Its StemPrintER Genomics-Based Personalized Medicine Business as a Separate Listed Company	Tiziana Life Sciences plc
21-May-2020	Mental health app Flow joins ORCHA App Library	ORCHA
21-May-2020	Clinical trials company calls for unity and action to address lack of patient diversity in research	Innovative Trials
21-May-2020	Santhera Completes Enrollment of Phase 3 SIDEROS Study with Puldysa® (Idebenone) in Duchenne Muscular Dystrophy (DMD)	Santhera Pharmaceuticals
21-May-2020	Yemen: In Aden’s only COVID-19 treatment centre we are seeing a catastrophe unfold	Doctors Without Borders
21-May-2020	Gilead and Galapagos Announce Positive Topline Results of Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis	Gilead
20-May-2020	Novadip Biosciences Reports Positive Interim Analysis of Phase I/II Bone Non-Union Study with NVD003	Novadip Biosciences
20-May-2020	BioMed X Institute Launches Rapid Antiviral Response Platform to Prevent Future Pandemics	BioMed X
20-May-2020	Alphega Pharmacy Members Receive Extra Support in Covid-19 Effort	Alphega Pharmacy
20-May-2020	Prime Global announces acquisition of Cambridge Medical Communication	Prime Global
20-May-2020	Minoryx Therapeutics doses first patient with leriglitazone in registration-enabling cALD NEXUS trial	Minoryx Therapeutics
20-May-2020	BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines	The Sabin Vaccine Institute (Sabin)
20-May-2020	Why research on ticks could offer potential COVID-19 breakthrough	ILC Therapeutics
20-May-2020	European Commission Approves Subcutaneous Formulation of Entyvio® (Vedolizumab) for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease	Takeda Pharmaceutical Company Limited
20-May-2020	4D Pharma: successful completion of immuno-oncology study safety phase	4D pharma plc
20-May-2020	New COVID-19 Antibody Testing Partnership Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK	Open Orphan plc
20-May-2020	GILEAD AND KITE CONTINUE TO ADVANCE NEXT GENERATION CANCER THERAPIES AT 2020 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING	Gilead Sciences, Inc.
20-May-2020	Nivolumab plus ipilimumab with chemotherapy shows improved overall survival vs. chemotherapy alone in first-line metastatic nonsmall cell lung cancer in a phase 3 trial	Bristol Myers Squibb
20-May-2020	Orgenesis announces cell-based vaccine platform targeting COVID-19 and other existing and emerging viral diseases	Orgenesis
20-May-2020	IDT broadens capacity and customer support of COVID-19 products with new manufacturing facility	Integrated DNA Technologies, Inc. (IDT)